LncRNA EILA promotes CDK4/6 inhibitor resistance in breast cancer by stabilizing cyclin E1 protein.
Cai Z, Shi Q, Li Y, Jin L, Li S, Wong LL, Wang J, Jiang X, Zhu M, Lin J, Wang Q, Yang W, Liu Y, Zhang J, Gong C, Yao H, Yao Y, Liu Q.
Cai Z, et al. Among authors: wang j, wang q.
Sci Adv. 2023 Oct 6;9(40):eadi3821. doi: 10.1126/sciadv.adi3821. Epub 2023 Oct 6.
Sci Adv. 2023.
PMID: 37801505
Free PMC article.